Cytotoxic chemotherapy remains an important component of anticancer therapy. However, newer ‘targeted agents’ and immunotherapy are emerging as more effective agents in certain cancer types, as determined by their molecular phenotype.
Cytotoxic chemotherapy remains an important component of anticancer therapy. However, newer ‘targeted agents’ and immunotherapy are emerging as more effective agents in certain cancer types, as determined by their molecular phenotype.